{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T10:11:16Z","timestamp":1768903876553,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jinf.2022.12.007","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T11:01:21Z","timestamp":1670670081000},"page":"154-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Real-life practice of the Egyptian Kelleni's protocol in the current tripledemic: COVID-19, RSV and influenza"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6290-6025","authenticated-orcid":false,"given":"Mina T.","family":"Kelleni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.12.007_bib0001","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jinf.2022.05.007","article-title":"A child with acute respiratory distress syndrome caused by avian influenza H3N8 virus","volume":"85","author":"Cheng","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2022.12.007_bib0002","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1016\/j.jinf.2022.08.033","article-title":"Human infection with H3N8 avian influenza virus: a novel H9N2-original reassortment virus","volume":"85","author":"Li","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2022.12.007_bib0003","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/tbed.14190","article-title":"Pathogenicity and transmissibility of current H3N2 swine influenza virus in Southern China: a zoonotic potential","volume":"69","author":"Yu","year":"2022","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.jinf.2022.12.007_bib0004","first-page":"14","article-title":"A characterization and an evolutionary and a pathogenicity analysis of reassortment H3N2 avian influenza virus in South China in 2019-2020","author":"Liu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jinf.2022.12.007_bib0005","series-title":"Fishman's Pulmonary Diseases and Disorders, 6e","article-title":"Viral infections of the lung and respiratory tract","author":"Treanor","year":"2023"},{"key":"10.1016\/j.jinf.2022.12.007_bib0006","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10787-021-00896-7","article-title":"NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown?","volume":"30","author":"Kelleni","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jinf.2022.12.007_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/14787210.2021.1939683","article-title":"NSAIDs\/nitazoxanide\/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects","volume":"20","author":"Kelleni","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jinf.2022.12.007_bib0008","first-page":"121","article-title":"NSAIDs\/Nitazoxanide\/azithromycin immunomodulatory protocol used in adult, geriatric, pediatric, pregnant, and immunocompromised COVID-19 patients: a real-world experience","volume":"3","author":"Kelleni","year":"2021","journal-title":"Can J Med"},{"key":"10.1016\/j.jinf.2022.12.007_bib0009","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1038\/s41598-018-28172-9","article-title":"Nitazoxanide inhibits paramyxovirus replication by targeting the Fusion protein folding: role of glycoprotein-specific thiol oxidoreductase","volume":"8","author":"Piacentini","year":"2018","journal-title":"ERp57. Sci Rep"},{"key":"10.1016\/j.jinf.2022.12.007_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2017.10.002","article-title":"The susceptibility of circulating human influenza viruses to tizoxanide, the active metabolite of nitazoxanide","volume":"147","author":"Tilmanis","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jinf.2022.12.007_bib0011","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","article-title":"Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenzaa","volume":"68","author":"Uyeki","year":"2019","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jinf.2022.12.007_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012060","article-title":"Anti-inflammatory effect of prophylactic macrolides on children with chronic lung disease: a protocol for a double-blinded randomised controlled trial","volume":"6","author":"Mosquera","year":"2016","journal-title":"BMJ Open"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:36:14Z","timestamp":1759008974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322006971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0163445322006971"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.12.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life practice of the Egyptian Kelleni's protocol in the current tripledemic: COVID-19, RSV and influenza","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}